Geode Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124M Buy
2,104,000
+146,904
+8% +$6.16M 0.01% 1057
2026
Q1
$63M Buy
1,957,096
+56,214
+3% +$2.08M ﹤0.01% 1365
2025
Q4
$80M Buy
1,900,882
+9,429
+0.5% +$380K ﹤0.01% 1219
2025
Q3
$64.9M Sell
1,891,453
-39,947
-2% -$1.15M ﹤0.01% 1328
2025
Q2
$52.2M Sell
1,931,400
-3,459
-0.2% -$100K ﹤0.01% 1398
2025
Q1
$57.4M Buy
1,934,859
+94,911
+5% +$3.62M ﹤0.01% 1303
2024
Q4
$72.9M Sell
1,839,948
-4,765
-0.3% -$180K 0.01% 1194
2024
Q3
$62.8M Buy
1,844,713
+17,921
+1% +$504K 0.01% 1284
2024
Q2
$39.6M Buy
1,826,792
+126,486
+7% +$2.66M ﹤0.01% 1513
2024
Q1
$37.7M Buy
1,700,306
+83,541
+5% +$2.04M ﹤0.01% 1547
2023
Q4
$44.5M Buy
1,616,765
+73,624
+5% +$1.78M ﹤0.01% 1416
2023
Q3
$34.5M Buy
1,543,141
+54,734
+4% +$1.41M ﹤0.01% 1481
2023
Q2
$37.9M Buy
1,488,407
+53,889
+4% +$1.31M ﹤0.01% 1432
2023
Q1
$32M Buy
1,434,518
+60,026
+4% +$1.45M ﹤0.01% 1488
2022
Q4
$32.6M Buy
1,374,492
+50,944
+4% +$1.18M ﹤0.01% 1447
2022
Q3
$22M Buy
1,323,548
+30,384
+2% +$684K ﹤0.01% 1662
2022
Q2
$25.7M Buy
1,293,164
+64,003
+5% +$1.29M ﹤0.01% 1574
2022
Q1
$33.9M Sell
1,229,161
-11,187
-0.9% -$320K ﹤0.01% 1528
2021
Q4
$51.1M Buy
1,240,348
+39,125
+3% +$1.73M 0.01% 1296
2021
Q3
$55.8M Buy
1,201,223
+11,753
+1% +$513K 0.01% 1183
2021
Q2
$47.6M Buy
1,189,470
+70,037
+6% +$2.99M 0.01% 1355
2021
Q1
$60.2M Buy
1,119,433
+219,832
+24% +$12.7M 0.01% 1086
2020
Q4
$44M Buy
899,601
+72,664
+9% +$3.37M 0.01% 1192
2020
Q3
$26.9M Buy
826,937
+89,355
+12% +$2.84M 0.01% 1310
2020
Q2
$19.1M Buy
737,582
+40,698
+6% +$1.01M ﹤0.01% 1541
2020
Q1
$16.9M Buy
696,884
+36,365
+6% +$915K ﹤0.01% 1414
2019
Q4
$18.4M Buy
660,519
+23,261
+4% +$602K ﹤0.01% 1617
2019
Q3
$15.3M Buy
637,258
+63,019
+11% +$1.68M ﹤0.01% 1651
2019
Q2
$16.4M Buy
574,239
+127,555
+29% +$3.19M ﹤0.01% 1619
2019
Q1
$11.2M Buy
446,684
+55,547
+14% +$1.06M ﹤0.01% 1821
2018
Q4
$4.92M Buy
391,137
+13,261
+4% +$157K ﹤0.01% 2241
2018
Q3
$3.61M Buy
377,876
+187,135
+98% +$2.06M ﹤0.01% 2573
2018
Q2
$1.78M Buy
190,741
+35,453
+23% +$249K ﹤0.01% 2920
2018
Q1
$863K Buy
155,288
+1,801
+1% +$11.1K ﹤0.01% 3193
2017
Q4
$1M Sell
153,487
-2,936
-2% -$21.8K ﹤0.01% 3101
2017
Q3
$1.37M Buy
156,423
+22,599
+17% +$184K ﹤0.01% 2970
2017
Q2
$1.11M Buy
133,824
+11,727
+10% +$95.7K ﹤0.01% 3058
2017
Q1
$1.12M Buy
122,097
+7,725
+7% +$63.2K ﹤0.01% 2963
2016
Q4
$885K Buy
114,372
+16,209
+17% +$121K ﹤0.01% 3050
2016
Q3
$747K Sell
98,163
-5,388
-5% -$30.5K ﹤0.01% 3087
2016
Q2
$520K Buy
103,551
+8,939
+9% +$47.9K ﹤0.01% 3213
2016
Q1
$510 Buy
94,612
+4,001
+4% +$23.7K ﹤0.01% 3228
2015
Q4
$652K Buy
90,611
+3,414
+4% +$23K ﹤0.01% 3136
2015
Q3
$408K Buy
87,197
+66
+0.1% +$628 ﹤0.01% 3315
2015
Q2
$970K Buy
87,131
+43,856
+101% +$432K ﹤0.01% 2908
2015
Q1
$315K Buy
43,275
+18,932
+78% +$155K ﹤0.01% 3402
2014
Q4
$235K Buy
24,343
+156
+0.6% +$1.22K ﹤0.01% 3523
2014
Q3
$235K Sell
24,187
-53
-0.2% -$696 ﹤0.01% 3508
2014
Q2
$414K Buy
24,240
+2,048
+9% +$29.5K ﹤0.01% 3239
2014
Q1
$380K Buy
+22,192
New +$354K ﹤0.01% 3268

Other funds holding VCYT

Geode Capital Management's VCYT Position: Q2 2026 in Review

Geode Capital Management increased its Veracyte (VCYT) stake by 7.5% in Q2 2026, buying an estimated $6.16M and bringing the position to 2,104,000 shares worth $124M. The position accounts for 0.01% of the portfolio, ranked #1057.

Geode Capital Management first reported a position in VCYT in Q1 2014 and has held it in 50 quarters since. 349 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Geode Capital Management held 2,104,000 shares of Veracyte worth $124M as of Q2 2026.
  • Geode Capital Management bought 146,904 Veracyte shares in Q2 2026, an estimated $6.16M.
  • Veracyte made up 0.01% of Geode Capital Management's portfolio in Q2 2026, its #1057 holding.
  • Geode Capital Management first reported a position in Veracyte in Q1 2014 and has held it in 50 quarters since.
  • 349 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.